Oxolife and its phase II asset OXO-001 for embryo implantation have been featured in the UK's highest circulated daily … [Read more...] about OXO-001, for embryo implantation makes headlines in the Daily News!
Oxolife in the radio
We are delighted to share the interview to our CEO Agnès Arbat on #Lideratges, Ariadna’s Belver Comin program, where … [Read more...] about Oxolife in the radio
At OXOLIFE we are celebrating!!
After a year since the start of our clinical trial and after the last milestone of end of recruitment, we want to share … [Read more...] about At OXOLIFE we are celebrating!!
Oxolife attend to ESHRE Congress 2022
These days the OXOLIFE team is in Milan (Italy) at European Society of Human Reproduction and Embryology (ESHRE) … [Read more...] about Oxolife attend to ESHRE Congress 2022
At @OXOLIFE we are celebrating!
After 9 months of recruiting women who are looking for pregnancy, we have finally passed our milestone with 403 patients … [Read more...] about At @OXOLIFE we are celebrating!
Oxolife in the News
Our CEO Agnes Arbat is interviewed at IB radio to talk about our OXOART2 Clinical trial. She explains the potential of … [Read more...] about Oxolife in the News